| Literature DB >> 10604272 |
E J Small1, D M Reese, N J Vogelzang.
Abstract
The treatment of advanced prostate cancer has evolved rapidly in the last several years. Therapeutic options for patients with advanced disease, once limited to the use of androgen deprivation, have expanded to include a number of interventions, including secondary hormonal manipulations, chemotherapy, and a variety of investigational approaches.Entities:
Mesh：
Substances：
Year: 1999 PMID： 10604272
Source DB: PubMed Journal: Semin Oncol ISSN： 0093-7754 Impact factor: 4.929